OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
KUVVA$161.5056

Kuvva Gida Ticaret ve Sanayi Yatirimlari AS

Food Retail & DistributionVerified

Kuvva Gida maintains a capital structure with a debt-to-equity ratio of 0.15, indicating a relatively low reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 0.58, suggesting limited short-term liquidity to cover immediate liabilities. Despite a negative net cash position after subtracting total debt, the company reported a free cash flow of 106,371,020 TRY, which may support ongoing operations and reinvestment. Profitability metrics show a return on equity (ROE) of 23.04% and a return on assets (ROA) of 17.84%, both exceeding typical thresholds for the Food Retail & Distribution industry. The company's gross profit margin is 78.9%, and its operating margin is 72.6%, indicating strong cost control and pricing power relative to industry norms. Geographic and segment exposure is not explicitly detailed in the available data, but the company's operations are concentrated in Turkey. No material revenue concentration is disclosed, and the company does not report segment-specific financials. The company's growth trajectory is mixed. Revenue for the latest period was 54,399,350 TRY, and while the company reported a net income of 159,097,590 TRY, the operating cash flow was negative at -194,303,230 TRY. Capital expenditures were -176,262,970 TRY, suggesting significant reinvestment in the business. Risk factors include a medium liquidity risk due to the current ratio of 0.58 and a negative net cash position. The company's dilution risk is assessed as low, with no near-term pressure from share issuance or dilutive events. The risk assessment also flags the negative net cash position as a key concern. Recent events include the latest actual EPS of 0.09 TRY and actual revenue of 10,238,000 TRY, as reported by analysts. No recent filings or transcripts are available to provide additional context on strategic or operational developments.

30-day price · KUVVA+28.60 (+22.1%)
Low$117.40High$164.60Close$158.10As of15 May, 00:00 UTC
Profile
CompanyKuvva Gida Ticaret ve Sanayi Yatirimlari AS
TickerKUVVA.IS
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Kuvva Gida Ticaret ve Sanayi Yatirimlari AS operates in the Food Retail & Distribution industry, primarily generating revenue through the sale of food and drug products in Turkey.

Classification. The company is classified under the Food Retail & Distribution industry within the Consumer Non-Cyclicals economic sector, with a confidence level of 0.92.

Kuvva Gida maintains a capital structure with a debt-to-equity ratio of 0.15, indicating a relatively low reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 0.58, suggesting limited short-term liquidity to cover immediate liabilities. Despite a negative net cash position after subtracting total debt, the company reported a free cash flow of 106,371,020 TRY, which may support ongoing operations and reinvestment. Profitability metrics show a return on equity (ROE) of 23.04% and a return on assets (ROA) of 17.84%, both exceeding typical thresholds for the Food Retail & Distribution industry. The company's gross profit margin is 78.9%, and its operating margin is 72.6%, indicating strong cost control and pricing power relative to industry norms. Geographic and segment exposure is not explicitly detailed in the available data, but the company's operations are concentrated in Turkey. No material revenue concentration is disclosed, and the company does not report segment-specific financials. The company's growth trajectory is mixed. Revenue for the latest period was 54,399,350 TRY, and while the company reported a net income of 159,097,590 TRY, the operating cash flow was negative at -194,303,230 TRY. Capital expenditures were -176,262,970 TRY, suggesting significant reinvestment in the business. Risk factors include a medium liquidity risk due to the current ratio of 0.58 and a negative net cash position. The company's dilution risk is assessed as low, with no near-term pressure from share issuance or dilutive events. The risk assessment also flags the negative net cash position as a key concern. Recent events include the latest actual EPS of 0.09 TRY and actual revenue of 10,238,000 TRY, as reported by analysts. No recent filings or transcripts are available to provide additional context on strategic or operational developments.
Key takeaways
  • Kuvva Gida has a strong ROE of 23.04% and ROA of 17.84%, indicating efficient use of equity and assets.
  • The company's liquidity position is medium, with a current ratio of 0.58 and a negative net cash position.
  • Free cash flow of 106,371,020 TRY supports ongoing operations and reinvestment despite a negative operating cash flow.
  • The company's debt-to-equity ratio of 0.15 suggests a conservative capital structure.
  • No material revenue concentration is disclosed, and the company's operations are primarily in Turkey.
  • Dilution risk is low, with no near-term pressure from share issuance.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyTRY
Revenue$54.4M
Gross profit$42.9M
Operating income$39.5M
Net income$159.1M
R&D
SG&A
D&A
SBC
Operating cash flow-$194.3M
CapEx-$176.3M
Free cash flow$106.4M
Total assets$891.7M
Total liabilities$201.2M
Total equity$690.6M
Cash & equivalents$33.2k
Long-term debt$103.7M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$3.6M-$451.0k$606.8k$645.2k
FY-3$51.9M$12.1M$3.4M-$19.4M
FY-2$105.9M$26.3M$139.8M-$17.5M
FY-1$1.34B-$67.8M$254.2M-$279.1M
FY0$961.1M$52.6M-$188.6M$56.8M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$24.5M$14.9M$0.00
FY-3$207.7M$70.5M$62.0k
FY-2$891.7M$690.6M$33.2k
FY-1$2.86B$712.3M$57.0k
FY0$2.59B$391.3M
PeriodOCFCapExFCFSBC
FY-4$8.8M-$10.0k$645.2k
FY-3-$96.4M-$27.1M-$19.4M
FY-2-$194.3M-$176.3M-$17.5M
FY-1$904.1M-$823.8M-$279.1M
FY0-$76.0M-$113.2M$56.8M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$54.4M$39.5M$159.1M$106.4M
FQ-6$11.8M-$3.2M$32.8M$40.2M
FQ-5$29.5M-$45.9M-$81.7M-$765.0M
FQ-4$94.8M-$15.1M-$89.6M-$164.3M
FQ-3$1.20B-$41.7M$352.6M$570.6M
FQ-2$153.0M$6.0M$119.2M-$297.0M
FQ-1$167.7M-$3.6M-$67.2M$390.4M
FQ0$118.1M$5.2M$33.0M$59.2M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$891.7M$690.6M$33.2k
FQ-6$811.6M$574.3M$92.8k
FQ-5$841.9M$561.5M$279.2k
FQ-4$857.8M$575.6M$0.00
FQ-3$3.33B$586.0M$74.6k
FQ-2$3.30B$965.7M$1.1M
FQ-1$2.69B$573.5M$18.9k
FQ0$2.84B$632.8M$0.00
PeriodOCFCapExFCFSBC
FQ-7-$194.3M-$176.3M$106.4M
FQ-6$38.8M-$755.4k$40.2M
FQ-5$688.8M-$688.4M-$765.0M
FQ-4$839.3M-$789.4M-$164.3M
FQ-3$904.1M-$823.8M$570.6M
FQ-2$361.6M-$427.7M-$297.0M
FQ-1$23.8M-$92.8M$390.4M
FQ0-$56.6M-$100.4M$59.2M
Valuation
Market price$161.50
Market cap$5.01B
Enterprise value$5.12B
P/E31.5
Reported non-GAAP P/E
EV/Revenue94.1
EV/Op income129.6
EV/OCF
P/B7.3
P/Tangible book7.3
Tangible book$690.6M
Net cash-$103.7M
Current ratio0.6
Debt/Equity0.1
ROA17.8%
ROE23.0%
Cash conversion-1.2%
CapEx/Revenue-3.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 184 companies
MetricKUVVAActivity
Op margin72.6%3.1% medp25 1.2% · p75 6.8%top quartile
Net margin292.5%2.0% medp25 0.7% · p75 4.1%top quartile
Gross margin78.9%26.1% medp25 17.2% · p75 32.0%top quartile
CapEx / revenue-324.0%-2.5% medp25 -4.6% · p75 -1.4%bottom quartile
Debt / equity15.0%56.0% medp25 16.8% · p75 121.1%bottom quartile
Observations
IR observations
Last actual EPS0.09 TRY
Last actual revenue10,238,000 TRY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 08:31 UTC#6accccc0
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 09:15 UTCJob: cc6e558f